#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4829311	F	Antibiotic adjuvant activity against meropenem-treated NDM-producing carbapenem resistant Klebsiella pneumoniae infected in BALB/c mouse sepsis model assessed as survival rate at 10 mg/kg, ip in the presence of meropenem measured after 7 days	Klebsiella pneumoniae	1		organism-based format	Scientific Literature
2.	ALA4829312	F	Antibiotic adjuvant activity against meropenem-treated NDM-producing carbapenem resistant Klebsiella pneumoniae infected in BALB/c mouse sepsis model assessed as mouse rescue at 10 mg/kg, ip in the presence of meropenem measured after 48 hrs	Klebsiella pneumoniae	2		organism-based format	Scientific Literature
3.	ALA4829313	F	Antibacterial activity against NDM-producing carbapenem resistant Klebsiella pneumoniae infected in BALB/c mouse sepsis model assessed as animal survival at 10 mg/kg, ip measured after 48 hrs	Klebsiella pneumoniae	2		organism-based format	Scientific Literature
4.	ALA4829314	F	Antibacterial activity against IMP-4 producing Escherichia coli DH5 alpha assessed as bacterial growth at 8 ug/ml incubated for 16 to 20 hrs by CLSI based microdilution method	Escherichia coli	2		organism-based format	Scientific Literature
5.	ALA4829315	B	Zinc chelation-dependent inhibition of NDM-1 (unknown origin) expressed in Escherichia coli BL21 (DE3) using meropenem as substrate preincubated with enzyme for 5 to 10 mins followed by substrate addition		8		assay format	Scientific Literature
6.	ALA4829316	B	Zinc chelation-dependent inhibition of VIM-2 (unknown origin) expressed in Escherichia coli BL21 (DE3) using nitrocefin as substrate preincubated with enzyme for 5 to 10 mins followed by substrate addition		8		assay format	Scientific Literature
7.	ALA4829317	B	Zinc chelation-dependent inhibition of IMP-4 (unknown origin) expressed in Escherichia coli BL21 (DE3) using imipenem as substrate preincubated with enzyme for 5 to 10 mins followed by substrate addition		8		assay format	Scientific Literature
8.	ALA4829318	F	Antibacterial activity against NDM-1 producing Escherichia coli DH5alpha assessed as decrease in bacterial growth incubated for 16 to 20 hrs by CLSI based microdilution method	Escherichia coli	5		organism-based format	Scientific Literature
9.	ALA4829319	F	Antibacterial activity against IMP-4 producing Escherichia coli DH5alpha assessed as decrease in bacterial growth incubated for 16 to 20 hrs by CLSI based microdilution method	Escherichia coli	5		organism-based format	Scientific Literature
10.	ALA4829320	F	Antibacterial activity against VIM-1 producing Escherichia coli DH5alpha assessed as decrease in bacterial growth incubated for 16 to 20 hrs by CLSI based microdilution method	Escherichia coli	5		organism-based format	Scientific Literature
11.	ALA4829321	F	Antibacterial activity against MBL producing Enterobacter cloacae isolates assessed as inhibition of bacterial growth at 64 ug/ml incubated for 16 to 20 hrs by CLSI based microdilution method	Enterobacter cloacae	2		organism-based format	Scientific Literature
12.	ALA4829322	F	Antibacterial activity against MBL producing Escherichia coli isolates assessed as inhibition of bacterial growth at 64 ug/ml incubated for 16 to 20 hrs by CLSI based microdilution method	Escherichia coli	2		organism-based format	Scientific Literature
13.	ALA4829323	F	Antibacterial activity against MBL producing Klebsiella pneumoniae isolates assessed as inhibition of bacterial growth at 64 ug/ml incubated for 16 to 20 hrs by CLSI based microdilution method	Klebsiella pneumoniae	2		organism-based format	Scientific Literature
14.	ALA4829324	F	Antibacterial activity against MBL producing Klebsiella oxytoca isolates assessed as inhibition of bacterial growth at 64 ug/ml incubated for 16 to 20 hrs by CLSI based microdilution method	Klebsiella oxytoca	2		organism-based format	Scientific Literature
15.	ALA4829325	F	Antibacterial activity against MBL producing Citrobacter freundii isolates assessed as inhibition of bacterial growth at 64 ug/ml incubated for 16 to 20 hrs by CLSI based microdilution method	Citrobacter freundii	2		organism-based format	Scientific Literature
16.	ALA4829326	F	Antibacterial activity against MBL producing Enterobacter hormaechei isolates assessed as inhibition of bacterial growth at 64 ug/ml incubated for 16 to 20 hrs by CLSI based microdilution method	Enterobacter hormaechei	2		organism-based format	Scientific Literature
17.	ALA4829327	F	Antibacterial activity against MBL producing Pseudomonas aeruginosa isolates assessed as inhibition of bacterial growth at 64 ug/ml incubated for 16 to 20 hrs by CLSI based microdilution method	Pseudomonas aeruginosa	2		organism-based format	Scientific Literature
18.	ALA4829328	F	Antibiotic adjuvant activity against meropenem-treated VIM-1 producing Escherichia coli DH5 alpha assessed as bacterial growth at 8 ug/ml incubated for 16 to 20 hrs in the presence of meropenem and 100 uM zinc sulfate by CLSI based microdilution method	Escherichia coli	2		organism-based format	Scientific Literature
19.	ALA4829329	F	Antibiotic adjuvant activity against meropenem-treated VIM-1 producing Escherichia coli DH5 alpha assessed as inhibition of bacterial growth at 8 ug/ml incubated for 16 to 20 hrs in the presence of meropenem and 1 to 10 uM zinc sulfate by CLSI based microdilution method	Escherichia coli	2		organism-based format	Scientific Literature
20.	ALA4829330	F	Antibiotic adjuvant activity against meropenem-treated VIM-1 producing Escherichia coli DH5 alpha assessed as bacterial growth at 8 ug/ml incubated for 16 to 20 hrs in the presence of meropenem by CLSI based microdilution method	Escherichia coli	2		organism-based format	Scientific Literature